Recurrent Stroke in a Young Patient with Embolic Stroke of Undetermined Source and Patent Foramen Ovale: Quo Vadis?
So far, there has been no generally accepted diagnostic and therapeutic algorithm for patients with embolic stroke of undetermined source (ESUS). As recent clinical trials on secondary stroke prevention in ESUS did not support the use of oral anticoagulation and the concept of ESUS comprises heterog...
Main Authors: | Katharina Feil, Johanna Heinrich, Aenne S. von Falkenhausen, Regina Becker, Clemens Küpper, Katharina Müller, Dennis C. Thunstedt, Moritz F. Sinner, Stefan Kääb, Lars Kellert |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2020-01-01
|
Series: | Case Reports in Neurology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/505180 |
Similar Items
-
A score of non-contrast transthoracic echocardiography to screen patent foramen ovale in patients with embolic stroke of undetermined source
by: Hui Zhang, et al.
Published: (2022-02-01) -
Percutaneous closure of patent foramen ovale
by: FX Kleber, et al.
Published: (2008-10-01) -
Patent Foramen Ovale Closure for Stroke Prevention and Other Disorders
by: Fareed Moses S. Collado, et al.
Published: (2018-06-01) -
Patent Foramen Ovale in Fetal Life, Infancy and Childhood
by: Bibhuti B. Das
Published: (2020-07-01) -
Patent Foramen Ovale and Stroke–Current Status
by: Oh Young Bang, et al.
Published: (2015-09-01)